FDA Approves Toshiba Skin Radiation Exposure Dose Tracking System

 

January 20, 2014

January 20, 2014 — Toshiba America Medical Systems’ Dose Tracking System allows clinicians to track X-ray skin dose exposure in real time during interventional procedures. The U.S. Food and Drug Administration cleared Toshiba’s Infinix-I cardiovascular X-ray systems for use in pediatric and adult cardiac and abdominal procedures.

Toshiba’s Dose Tracking System displays live and cumulative radiation exposure through an color-coded indicator on a 3-D visualization of the patient. The display shows where radiation is being administered on the patient’s body in real time. The technology is intended to help clinicians appropriately distribute skin doses and minimize risk of locally concentrated high exposure.
 
The Dose Tracking System was developed in a partnership with the University of Buffalo. 
 
For more information: www.medical.toshiba.com

 

The content of this field is kept private and will not be shown publicly.
Type the characters you see in this picture. (verify using audio)
Type the characters you see in the picture above; if you can't read them, submit the form and a new image will be generated. Not case sensitive.